BIOTRONIK - SaFety and Performance Registry for an All-comers Patient Population With the SiroLimus Eluting Orsiro Stent Within Daily Clinical Practice in Small Vessels
Phase of Trial: Phase IV
Latest Information Update: 21 Sep 2018
Price : $35 *
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms BIOFLOW-SV
- Sponsors BIOTRONIK
- 12 Sep 2018 Planned End Date changed from 1 May 2020 to 1 Aug 2020.
- 12 Sep 2018 Planned primary completion date changed from 1 May 2019 to 1 Aug 2019.
- 12 Sep 2018 Status changed from not yet recruiting to recruiting.